Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Get2PrEP2-A Provider Messaging Strategy to Improve PrEP Uptake: A Randomized Controlled Quality Improvement Project.
Zucker J, Castor D, Theodore D, Carnevale C, Osilama E, Archer N, Bonadonna L, Wadden E, Morley N, Huang S, Meyers K, Cohall A, Gordon P, Sobieszczyk ME. Zucker J, et al. Among authors: castor d. Open Forum Infect Dis. 2024 Jun 20;11(6):ofae297. doi: 10.1093/ofid/ofae297. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38911948 Free PMC article. Clinical Trial.
Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review.
Castor D, Heck CJ, Quigee D, Telrandhe NV, Kui K, Wu J, Glickson E, Yohannes K, Rueda ST, Bozzani F, Meyers K, Zucker J, Deacon J, Kripke K, Sobieszczyk ME, Terris-Prestholt F, Malati C, Obermeyer C, Dam A, Schwartz K, Forsythe S. Castor D, et al. J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26110. doi: 10.1002/jia2.26110. J Int AIDS Soc. 2023. PMID: 37439063 Free PMC article. Review.
Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.
Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, Vlahov D, Dezzutti CS. Bower WA, et al. Among authors: castor d. J Acquir Immune Defic Syndr. 2006 Jul;42(3):293-7. doi: 10.1097/01.qai.0000221689.77220.42. J Acquir Immune Defic Syndr. 2006. PMID: 16763522
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.
Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, Miller MD, Emery S, van Leth F, Robinson P, Baxter JD, Perez-Elias M, Castor D, Hammer S, Rinehart A, Vermeiren H, Van Craenenbroeck E, Bacheler L. Winters B, et al. Among authors: castor d. J Acquir Immune Defic Syndr. 2008 May 1;48(1):26-34. doi: 10.1097/QAI.0b013e31816d9bf4. J Acquir Immune Defic Syndr. 2008. PMID: 18360290
Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services.
Njeuhmeli E, Hatzold K, Gold E, Mahler H, Kripke K, Seifert-Ahanda K, Castor D, Mavhu W, Mugurungi O, Ncube G, Koshuma S, Sgaier S, Conly SR, Kasedde S. Njeuhmeli E, et al. Among authors: castor d. J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S193-9. doi: 10.1097/QAI.0000000000000179. J Acquir Immune Defic Syndr. 2014. PMID: 24918595 Review.
Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
Lyons CE, Ketende S, Diouf D, Drame FM, Liestman B, Coly K, Ndour C, Turpin G, Mboup S, Diop K, Toure-Kane C, Castor D, Leye-Diouf N, Baral S. Lyons CE, et al. Among authors: castor d. J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1(Suppl 1):S52-S59. doi: 10.1097/QAI.0000000000001209. J Acquir Immune Defic Syndr. 2017. PMID: 27930612 Free PMC article.
101 results